FOLLISTIM Drug Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Tradename: FOLLISTIM
| High Confidence Patents: | 4 |
| Applicants: | 1 |
| BLAs: | 3 |
| Drug Prices: | Drug price information for FOLLISTIM |
| Recent Clinical Trials: | See clinical trials for FOLLISTIM |
Recent Clinical Trials for FOLLISTIM
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Ferring Pharmaceuticals | Phase 2 |
| Center for Human Reproduction | Phase 1/Phase 2 |
| Michigan Reproductive Medicine | Phase 4 |
Note on Biologic Patents
Matching patents to biologic drugs is far more complicated than for small-molecule drugs.
DrugPatentWatch employs three methods to identify biologic patents:
- Brand-side disclosures in response to biosimilar applications
- General brand-side disclosures
- Patents from broad patent text search
These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.
These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.
For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.
1) High Certainty: US Patents for FOLLISTIM Derived from Brand-Side Litigation
No patents found based on brand-side litigation
2) High Certainty: US Patents for FOLLISTIM Derived from Company Disclosures
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ | follitropin beta | Injection | 021273 | ⤷ Try a Trial | 2017-01-15 | Company disclosures |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ CARTRIDGE | follitropin beta | Injection | 021211 | ⤷ Try a Trial | 2015-06-16 | Company disclosures |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ CARTRIDGE | follitropin beta | Injection | 021211 | ⤷ Try a Trial | 2017-01-15 | Company disclosures |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ CARTRIDGE | follitropin beta | Injection | 021211 | ⤷ Try a Trial | 2018-07-23 | Company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
3) Low Certainty: US Patents for FOLLISTIM Derived from Patent Text Search
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM | follitropin beta | For Injection | 020582 | ⤷ Try a Trial | 2033-03-11 | Patent claims search |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM | follitropin beta | For Injection | 020582 | ⤷ Try a Trial | 2024-12-29 | Patent claims search |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM | follitropin beta | For Injection | 020582 | ⤷ Try a Trial | 2029-05-13 | Patent claims search |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM | follitropin beta | For Injection | 020582 | ⤷ Try a Trial | 2029-01-29 | Patent claims search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
International Patents for FOLLISTIM
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 020618 | ⤷ Try a Trial |
| European Patent Office | 0957167 | ⤷ Try a Trial |
| Germany | 211894 | ⤷ Try a Trial |
| Hungary | 227154 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for FOLLISTIM
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C960004 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: RECOMBINANT HUMAAN FOLLIKELSTIMULEREND HORMOON; REGISTRATION NO/DATE: EU/1/95/001/001 - EU/1/95/001/016 19951020 |
| 426 | Finland | ⤷ Try a Trial | |
| 132010901848521 | Italy | ⤷ Try a Trial | PRODUCT NAME: CORIFOLLITROPINA ALFA(ELONVA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/09/609/001-002, 20100125 |
| C201000010 | Spain | ⤷ Try a Trial | PRODUCT NAME: CORIFOLITROPINA ALFA; NATIONAL AUTHORISATION NUMBER: EU/1/09/609/001-002; DATE OF AUTHORISATION: 20100125; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/09/609/001-002; DATE OF FIRST AUTHORISATION IN EEA: 20100125 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
